Dabigatran of etexilate (paradox®) for the patients with closed diaphyseal fractures of the femur and tibia

Abstract

The results of application of dabigatran etexilate in treatment of 56 patients aged 60 to 89 with closed diaphyseal fractures of femur and tibia undergone intramedullary osteosynthesis were studied. The patients were divided into 2 groups. The first group consisted of patients receiving standard anticoaqulant therapy. The second one included patients who used etyek-silat (pradaxa OS) in early postoperative period. The results of treatment in these groups were analysed and compared. Evidence-based significant advantage of dabigatran etexilate (pradaxaR) administration in early postoperative period was revealed.

Keywords

• диафизарный перелом бедра и голени
• интрамедуллярный остеосинтез
• diaphyseal fractures of femur and tibia
• intramedullary osteosunthesis